HomeCompareAQNA vs MRK

AQNA vs MRK: Dividend Comparison 2026

AQNA yields 5.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AQNA wins by $8.25M in total portfolio value
10 years
AQNA
AQNA
● Live price
5.14%
Share price
$25.10
Annual div
$1.29
5Y div CAGR
64.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.31M
Annual income
$6,604,271.00
Full AQNA calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AQNA vs MRK

📍 AQNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAQNAMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AQNA + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AQNA pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AQNA
Annual income on $10K today (after 15% tax)
$436.54/yr
After 10yr DRIP, annual income (after tax)
$5,613,630.35/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AQNA beats the other by $5,605,301.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AQNA + MRK for your $10,000?

AQNA: 50%MRK: 50%
100% MRK50/50100% AQNA
Portfolio after 10yr
$4.18M
Annual income
$3,307,034.57/yr
Blended yield
79.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AQNA
No analyst data
Altman Z
0.3
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AQNA buys
0
MRK buys
0
No recent congressional trades found for AQNA or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAQNAMRK
Forward yield5.14%2.76%
Annual dividend / share$1.29$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR64.9%32.7%
Portfolio after 10y$8.31M$56.8K
Annual income after 10y$6,604,271.00$9,798.13
Total dividends collected$8.13M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AQNA vs MRK ($10,000, DRIP)

YearAQNA PortfolioAQNA Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,547$846.89$11,206$366.19+$341.00AQNA
2$13,862$1,507.05$12,650$502.35+$1.2KAQNA
3$17,621$2,788.26$14,407$694.19+$3.2KAQNA
4$24,316$5,462.16$16,585$967.82+$7.7KAQNA
5$37,635$11,616.48$19,342$1,363.89+$18.3KAQNA
6$67,977$27,707.94$22,913$1,947.19+$45.1KAQNA
7$149,864$77,128.19$27,662$2,823.89+$122.2KAQNA
8$422,404$262,049.04$34,159$4,173.35+$388.2KAQNA
9$1,590,253$1,138,280.96$43,337$6,308.80+$1.55MAQNA
10$8,305,842$6,604,271.00$56,776$9,798.13+$8.25MAQNA

AQNA vs MRK: Complete Analysis 2026

AQNAStock

Algonquin Power & Utilities Corp. operates in the power and utility industries in the United States, Canada, and other regions. The company operates in two segments, Regulated Services Group and Renewable Energy Group. The company primarily owns and operates a regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations. As of December 31, 2023, it provided distribution services to approximately 1,256,000 customer connections in the electric (approximately 309,000 customer connections), water and wastewater (approximately 572,000 customer connections), and natural gas sectors (approximately 375,000 customer connections). The company’s electrical distribution utility systems and related transmission and generation assets are located in the states of Arkansas, California, Kansas, Missouri, Nevada, New Hampshire, and Oklahoma, and in Bermuda. Its regulated water distribution and wastewater collection utility systems are located in the states of Arizona, Arkansas, California, Illinois, Missouri, New York and Texas, and in Chile. The company’s regulated natural gas distribution utility systems located in the province of New Brunswick and the states of Georgia, Illinois, Iowa, Massachusetts, Missouri, New Hampshire and New York. It also owns and operates generating assets with a gross capacity of approximately 2.0 gigawatt (GW) and has investments in generating assets with approximately 0.3 GW of net generation capacity. The company generates and sells electrical energy, capacity, ancillary products, and renewable attributes produced by its renewable and clean power generation facilities. It has economic interests in hydroelectric, wind, solar, renewable natural gas, and thermal facilities. As of December 31, 2023, it had a combined net generating capacity attributable to the Renewable Energy Group of approximately 2.7 GW. The company was incorporated in 1988 and is headquartered in Oakville, Canada.

Full AQNA Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AQNA vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AQNA vs SCHDAQNA vs JEPIAQNA vs OAQNA vs KOAQNA vs MAINAQNA vs JNJAQNA vs ABBVAQNA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.